Belong – Beating Cancer Together

The world’s largest social and professional network for managing and navigating treatment journeys

Free and anonymous for cancer patients and caregivers

Belong – Beating Cancer Together

The world’s largest social and professional network for managing and navigating treatment journeys

Free and anonymous for cancer patients and caregivers

Meet Dave
BelongAI Cancer Mentor App

The world’s first proactive conversational AI cancer mentor. A must have for every cancer patient.

Circle 1 new

Improving patient quality of life & quality of care worldwide,
through technology, services, data and AI

Belong News

Maintaining a positive outlook during a cancer battle can be tough, but it’s important for…
In today’s fast-paced world, ultra-processed foods have become a staple in many diets. However, for…
If you have chronic medical conditions (coexisting conditions) in addition to cancer, it’s important to…
Belong app logo
Beating Cancer Together

The world’s largest social
& professional network
for cancer patients

App Store
Belong Cancer App IMG 1

A Glance at Our Features

Direct Chats - Belong Cancer App

Direct Chats with World-Renowned Experts

Leading experts address questions asked by both patients and caregivers in various professional groups, including: oncology, radiology, researchers, doctors in various fields and experts in allied disciplines who provide patients with reliable and educational information.

Dave- AI Cancer Mentor

Dave is Belong’s artificial intelligence (AI) platform which provides patients with empathetic and personalized answers to cancer-related questions and concerns. Dave is able to provide cancer-specific, precise, comprehensive, and empathetic answers to patients’ challenges.

Belong Cancer App Features 2

Care Plan and Treatment Management

provides tips, reminders, helps to prepare for the next task. Improve the process and the experience for the patient and his family.
Help to understand what worked for others in similar situations makes it possible to decide on relevant alternatives and make informed decisions, on timelines and according to the stages of treatment.

A Supportive & Interactive Patient Community

An attentive and supportive social network of patients and caregivers tailored to each patient’s and their specific needs, interests, concerns and passions.
The forums provide assistance and support: users share their personal experiences, tips and information. They support one another through coping with daily challenges, recovery and the many other facets of the journey.

Supportive Patient Community - Cancer App
Personalized content, updates and news flashes in app

Personalized Content and Medical Binder

Breakthrough artificial intelligence (AI), machine learning (ML) and big data capabilities enable personalized content and updates as well as treatment navigation tools that provide tips and reminders every step of the way. All your health records are organized digitally in one place and can be shared privately with family members, friends, and medical professionals.

Clinical Trial Matching Service

Belong’s matching features uses machine learning and clinical trial-specific NLP algorithms to analyse and notify users of available & relevant clinical trials around the globe.

Clinical trial matching service in app

Our Experts

Prof. Irit Avivi
Prof. Irit Avivi
Head of Hematology Division at Tel-Aviv Sourasky Medical Center

Belong group – Ask the Hemato-oncologist
Prof. Irit Avivi is the Head of the Hematology Division at the Tel-Aviv Sourasky Medical Center and a Senior Lecturer at the Faculty of Medicine at the Technion Institute of Technology. She completed her MD with honors at the Technion, internship, residency and fellowship at the Rambam Medical Center and postgraduate fellowship at the Hematology Dep. at the University College London Hospitals, London, UK and became Senior attending physician responsible for the Lymphoma and Myeloma Service at the Dep. of Hematology at the Rambam Medical Center. Prof. Avivi has been involved in many clinical trials and scientific meetings and achieved several research accomplishments. She published many scientific publications. Prof. Avivi is a member of many professional associations worldwide.

Prof Michal Lotem
Prof Michal Lotem
Head of Center for Melanoma and Cancer Immunotherapy

Belong group – Melanoma MD
Prof. Michal Lotem is the head of the center for melanoma and Cancer Immunotherapy at the Hadassah Medical Center. Prof. Lotem participated in pivotal clinical trials that led to FDA’s approvals and is conducting anti-cancer vaccination protocols. Most recent is the use of engineered cancer cells with improved properties of activating immune cells. Prof. Lotem graduated at the Sackler School of Medicine, Tel Aviv University, has a Board Certification in Dermatology and Clinical and Radiation Oncology. She conducted her post-doctoral research fellowship at NCI, Bethesda, MD and is a visiting professor at Ronald Levy’s lab, pioneer of Monoclonal antibody-based lymphoma therapy and cancer immunotherapy, Stanford, CA. Prof. Lotem’s belief is that researcher clinicians should be the motivating force to guide scientific research to meet the acute needs of developing and advancing cancer cure.

Prof. Aron Popovtzer
Prof. Aron Popovtzer
Head, Sharett institute of Oncology

Belong group – Head & Neck Cancers MD
Prof. Aron Popovtzer graduated from Hebrew University, School of Medicine and completed his residency in Otolaryngology and H&N Surgery in Rabin Medical Center, followed by residencies in both Medical and Radiation oncology which he completed in the Davidoff Cancer center. He completed a two year fellowship in Head and neck cancer in the University of Michigan Ann Arbor and Brachytherapy Fellowship in Memorial Sloan Kettering NYC. Prof. Popovtzer is Head of the Sharett institute of Oncology, ENT, Medical & radiation oncologist specialist. Prof. Popovtzer is also the Chairman of the Israel Head and Neck Society, and an active member in the American Head and Neck Society and the EORTC. He has published over 60 papers and is an associate clinical Professor in the Tel Aviv University. His research focuses on tailored medicine for radiosentization genomic sequencing in unusual carcinomas and highly conformal irradiation of head and neck cancer.

Dr. Moshe Gatt
Prof. Moshe Gatt
Head of Hematology Division at Hadassah MC

Belong group – Ask the Hemato-oncologist
Prof. Moshe Gatt the Head of the Hematology Department at the Hadassah Hebrew University MC. He completed MD studies in 1999, his Internal Medicine residency in 2004 and Hematology fellowship in 2007. In 2007-2009 Dr. Moshe Gatt completed a scientific fellowship at The Jerome Lipper center for Multiple Myeloma, at the Dana Farber Cancer Institute, Harvard Medical School, Boston, MA. Subsequently. Dr. Moshe Gatt personal and scientific interest is in Myeloma and Amyloidosis,and he is chairman of the Israeli Multiple Myeloma study group. He is a member of the Israeli and the American Societies of Hematology.

Prof. Danny Rosin
Prof. Danny Rosin
Head, Ambulatory Surgery Department & Deputy, Department of General Surgery and Transplantation

Belong group – Surgical Breast Cancer MD
Prof. Danny Rosin is Head of the Ambulatory Surgery Department & Deputy of the Department of General Surgery and Transplantation at Sheba Medical Center. He finished his medical studies, with distinction, at Tel Aviv University. He completed his surgical residency at the Sheba Medical Center, including a year of training at the Mount Sinai Medical Center in New York. After becoming attending surgeon, he completed an 18 months fellowship in minimally invasive surgery at the Cleveland Clinic in Florida. For the last 18 years Prof. Rosin has been a senior surgeon in the department of general surgery and transplantations at Sheba Medical Center, and practices a wide variety of general surgery procedures, including breast surgery, hernia surgery, colon cancer operations and various advanced laparoscopic procedures. Prof. Rosin was awarded twice as outstanding physician.

Prof. Shahar Frenkel
Prof. Shahar Frenkel
Head of Ocular Oncology

Belong group – Eye Cancers
Prof. Shahar Frenkel is a clinician-scientist, an Ocular Oncologist and Ophthalmic Pathologist, and the head of the Ocular Oncology Laboratory at the Hadassah-Hebrew University Medical Center. He is a graduate of the Hebrew University in Jerusalem’s MD-PhD program. He was trained at Hadassah, Jerusalem, Israel, and at UIC, Chicago, IL, USA. Prof. Frenkel served on the board of the International Society of Ocular Oncology and is currently on the board of the Israeli Society for Vision and Eye Research. Prof. Frenkel diagnoses and treats any kind of eye cancer, he developed surgical techniques for the treatment of eye cancers, and he is striving to develop new biological therapies for cancer. Prof. Frenkel is the consulting Ophthalmologist for clinical trials for a variety of cancers.

Prof. Ra’anan Berger
Director, Cancer Center, Sheba Medical Center

Prof. Raanan Berger is the Director of the Cancer Center at the Sheba Medical Center. He completed clinical training in Medical Oncology and Radiotherapy at Sheba. Did his postdoctoral fellowship at Dana Farber Cancer Institute at Harvard Medical School. During this time, he combined clinical work treating prostate cancer patients (with Dr. Philip Kantoff) with basic research at Dr. William C. Hahn’s lab. He also developed a novel prostate cancer model derived from primary human prostate epithelial cells with defined genetic elements.

Prof. Gal Markel
Director of the Davidoff Cancer Center

Belong Group – Immunotherapy Oncologist
Prof. Gal Markel is the Director of the Davidoff Cancer Center and & Deputy Director General, Rabin Medical Center at Clalit Health Services. His clinical and research interests are melanoma and cancer immunotherapy. As a physician-researcher, he aims to define clinically-important challenges in the field of immuno-oncology, create technological solutions and thereby improve patient care. His work was published in more than 90 articles and recognized by multiple national and international agencies, including TED MED, ISF, Israel cancer association, Melanoma Research Alliance, Wolf Foundation, and others.

Dr. Ravit Geva
Prof. Ravit Geva
Head, GIT malignancies Center

Belong group – Colo-Rectal Cancer MD, Neuro Endocrine Tumors MD
Prof. Ravit Geva is a medical oncologist, Head of GIT malignancies Center, Head of Research Unit, Deputy Director Division of Oncology. She graduated medical school with honors at the Ben-Gurion University and followed by a residency in Medical oncology in the Tel-Aviv Sourasky Medical center. Prof. Geva did a fellowship in GIT malignancies under the guidance of prof. Eric Van Cutsem in the Clinical Digestive Oncology Department in Leuven, Belgium. She further specialized in the development of investigational drugs and clinical trials in Oxford University where she did her MSc in Experimental Therapeutics. Prof. Geva heads the Gastrointestinal Malignancies Center as well as the Oncology Research Unit at the Tel-Aviv Sourasky medical center in Israel. She is the chair of CTrials, The Israeli Association for Research and the Advancement of the Biomedical Community.

Dr. Ronit Elhasid
Prof. Ronit Elhasid
Head of the Pediatric hemato-oncology unit

Belong group – Children Oncology MD
Prof. Ronit Elhasid Head of the Pediatric hemato-oncology and bone marrow transplant department at the Tel Aviv Sourasky Medical Center, since 2011. Prof. Ronit Elhasid has been treating children with Leukemia and those undergoing stem cell transplants for over two decades. Since 2014, she is serving as the head of the national protocol for ALL relapse during childhood which is part of the international protocol. Throughout the years, she has been taking part in dozens of clinical trials and participating in multiple professional associations, worldwide. Prof. Ronit Elhasid his a senior lecturer at the Sackler Faculty of Medicine.

Prof. Talia Golan
Head of Pancreatic Cancer Center, Sheba Medical Center

Belong Group – Pancreatic Cancer MD
Prof. Talia Golan’s clinical expertise is with gastro-intestinal cancer, particularly pancreatic cancer, in which she is developing a lab-based model. In 2009 Prof. Golan co-founded The Early Phase Clinical Trials Program. Together with a dedicated phase-I team she has built an infrastructure that has augmented existing scientific programs at Sheba, enabling accelerated identification of prospective patients to benefit from discoveries; coordinate and facilitate feedback to scientists. She investigates the biology of pancreatic cancer and is developing an innovative model based on primary tumor cells.  Her careers aim include expertise in clinical medicine, translational laboratory research, and drug development.

Dr. Eyal Morag
CMO ImPact Biotech, Medical Director Aidoc Medical

Belong group – Ask the Imaging Expert
Dr. Eyal Morag, M.D. CMO ImPact Biotech, Medical Director Aidoc Medical. Was Chairman of Radiology at the Assuta Ashdod Medical Center. Graduated from Boston University School of Medicine in Boston, MA. He interned in medicine at Brockton Hospital, Brockton, MA. Dr. Eyal Morag completed his Radiology residency at Harvard Medical School, where he also received fellowship training in cardiovascular and interventional radiology. He then joined private practice in Western MA where he served as Chief of Radiology for several years. He then moved to Toledo, Ohio where he was the Regional Radiology Director for Mercy Health Hospitals. Dr. Eyal Morag is certified by the American Board of Radiology.

Dr. Eli Sapir
Dr. Eli Sapir
Chairman, Radiation Oncology, Assuta Medical Center

Belong group – Ask the Radiation Oncologist
Dr. Eli Sapir, Chairman at the Samson Assuta Ashdod University Hospital, Israeli Board Certified Radiation Oncologist, with a resume of a clinical and research fellowship at the Radiation Oncology Department of the University of Michigan, Ann Arbor. A member of the American Society for Therapeutic Radiology and Oncology (ASTRO), as well as the American Society for Clinical Oncology (ASCO). Dr. Eli Sapir personal interest and research are dedicated to head and neck tumors as well as gastrointestinal tumors, including stereotactic body radiotherapy of primary and secondary liver lesions.

Dr ido laskov
Dr. Ido Laskov
Gynecologic Oncologist, Tel Aviv Sourasky Medical

Belong group – Ask the Gyne-oncologist
Dr. Ido Laskov completed 6 years of residency in Obstetrics & Gynecology at the Tel Aviv Sourasky Medical Center and then completed a 3-year research & clinical sub-specialty in Gynecologic Oncology at the McGill University in Montreal, Canada. His training includes medical management of women with gynecological malignancies and he specializes in performing complex oncologic surgeries including pelvic, abdominal, laparoscopic and robotic surgeries. His research interests are in novel therapeutic interventions in women’s cancers for which he was able to publish a number of papers and has presented at national and international meetings. Currently Dr. Ido Laskov is the Deputy director of the Gynecologic Oncology department at the Tel Aviv Sourasky Medical Center.

Dr. Leonardo Lustgarten
Medical Director of Neurosurgery and Neuro-oncology at Novocure

Belong group – Neurosurgical MD

Medical Director of Neurosurgery and Neuro-oncology at Novocure. His area of interest is malignant brain tumors, and he led the largest recent trial on Glioblastoma with the use of Tumor Treating Fields (Trident trial). Dr. Lustgarten completed his neurosurgical training in Caracas, Venezuela and at the Radcliffe Infirmary (University of Oxford) under the sponsorship of the Royal College of Surgeons of England and General Medical Council (UK). He has over 23 years of neurosurgical and radiosurgical experience in the treatment of malignant and benign brain tumors. He has published extensively in scientific journals and book chapters and lectured internationally. Active member of various Neurosurgical Societies and a neurosurgical consultant to various academic institutions.

Dr. Ilya Lofin
Chief of Orthopedic Oncology Service at Mount Sinai Hospital

Belong group – Orthopaedic-Oncology MD

Chief of Orthopedic Oncology Service at Mount Sinai Hospital in New York. He specializes in the treatment of benign and malignant tumors of bone and soft tissue in patients of all ages. He treats tumors that arise within muscle and bone, such as sarcomas, as well as cancers that spread to bone, such as lung, breast, prostate, and kidney cancer. The treatment options range from observation to minimally invasive procedures to extensive limb sparing surgeries.

Dr. Lofin undergraduate at Princeton University and his medical training was at Washington University School of Medicine. He completed residency in orthopedic surgery at NYU Hospital for Joint Diseases followed by fellowship in orthopedic oncology at The Washington Hospital Center/Georgetown University.

Dr. Moti Avner
Melanoma & Immunotherapy specialist

Dr. Moti Avner is a Melanoma & Immunotherapy specialist. He is a senior medical oncologist at Sharet Institute, at Hadassah medical center, Jerusalem. Dr. Avner has a special interest in cancer genetics, cancer in young adults, and health services digitation.

Dr. Dan Mirelman
A senior oncologist at the Gastrointestinal Tumors Unit

Belong group – Colo-Rectal Cancer MD

A senior oncologist at the Gastrointestinal Tumors Unit, in the Tel Aviv Medical Center, Ichilov.  He treats patients diagnosed with colon cancer, rectal cancer, and various tumors in the upper GI tract, including pancreatic and biliary tract tumors. As part of his work at the clinic, he integrate clinical research and take an active part in clinical studies, and serves as a sub-investigator in first phase studies in the Ichilov research unit.

Dr. Mirelman finished his medical studies in the 4-year program at Tel Aviv University and started an internship in the oncology unit in Ichilov. He participates in tumor boards and in multidisciplinary meetings. He participates in conferences in Israel and around the world, dealing with tumors of the GI tract.

Dr. Barliz Waissengrin
Dr. Barliz Waissengrin
Senior Medical Oncologist

Belong group – Ask the Oncologist
Dr. Barliz Waissengrin is a senior medical Oncologist in the Oncology Institute at Tel Aviv Medical Center in Tel Aviv. Dr. Waissengrin graduated from Ben Gurion University Medical School with distinction as part of the military reserve and afterward she served as a medical officer at the IDF. Next, she completed a Medical Oncology internship at the Oncological Institute of Tel Aviv Medical Center. Today Dr. Waissengrin runs a busy clinic for breast and lung cancer along with diverse academic work mainly in the field of Lung Cancer, side effects of treatments, and the influence of palliation on treatments’ efficacy.
Dr. Barliz Waissengrin is part of the ESMO, IASLC and ISCORT.

Dr. Eytan Ben Ami
Dr. Eytan Ben Ami
Deputy, Cancer Division, Sheba Medical Center

Belong group – Sarcoma MD
Dr. Eytan Ben-Ami is Deputy of Cancer Division at Sheba Medical Center. He completed medical oncology residency at the Chaim Sheba Medical Center in 2015. Between 2015-2018 he worked as a research scholar in the department for sarcoma and bone oncology at the Dana-Farber Cancer Institute in Boston, where he focused his research on investigational therapies in patient derived xenograft models (PDX) in mice, as well as the potential of targeted therapies in the various sarcoma subtypes. Dr. Eytan Ben-Ami clinical focus is on the multidisciplinary and treatment approach to localized and advanced soft-tissue and bone sarcomas in adults.

Dr. Maya Gottfried
Dr. Maya Gottfried
Director of the Oncology Institute

Belong group – Lung Cancer MD.
Dr. Maya Gottfried is the Director of the Oncology Institute at the Meir Medical Centre and a Senior Lecturer at the Tel Aviv School of Medicine. She completed her MD at the University of Padua, Italy and became a Senior Specialist in Internal Medicine at the Meir Medical Centre and later Chief Resident in the Oncology Department at Sheba Medical Centre and Instructor of Internal Medicine at the Tel Aviv School of Medicine. She completed a Fellowship in Medical Oncology at the Institute of Oncology Gustave-Roussy, in France, before returning as Chief Resident to the Oncology Department of Sheba Medical Centre and Meir Medical Centre. Dr Gottfried was appointed Senior Specialist in Oncology and Radiation at the Sheba and Meir Medical Centres, and later as Head of the Lung Oncology Unit at the Meir Medical Centre. Dr Gottfried has been involved extensively in clinical trials on non-small cell lung cancer acting as Principal Investigator. She is a member of many associations worldwide.

Dr. Ron Lavy
Dr. Ron Lavy
Head of Surgery B. Shamir Medical Center

Belong group – Surgical Oncology MD
Dr. Ron Lavy is the Head of Surgery B at Shamir Medical Center, Israel. He received his MD degree from Tel Aviv Sackler school of Medicine and completed residency training at Assaf Harofeh. Dr. Lavy completed his 2 years fellowship in the Dep. of Surgical Oncology at the University of Illinois, Chicago, before returning as a senior general surgery to Assaf Harofeh. Dr. Lavy has been involved in the publications of many professional papers and is a member in the Israeli Medical Association, Surgical Association, Israel society of Surgical Oncology and the Israel society of Colorectal Surgery.

Dr. Avivit Peer - Belong Life
Dr. Avivit Peer
Genitourinary Clinic, Rambam Medical Center

Belong group – Kidney & Bladder Cancer MD
Dr. Avivit Peer is a senior doctor at the Oncology Division at Rambam Medical Center, in charge of the kidney and urinary cancer clinic, and heads the oncology clinical trial unit. She graduated life science studies and med school with honors and specialized in oncology at the Rambam Medical Center. She studied the field of clinical trials in France and testicular cancer in the US. She lectures at the medical faculty of the Technion Institute, and received several recognition awards for her activity in medical education. She is a member in several oncology associations in Israel and the US. Alongside patient treatment and clinical trials, Dr. Peer’s center of activity is the development of oncology clinical trial methods, including research into groundbreaking cancer drugs and early stage drug effect on cancer patients and its effect on new drug development.

Dr. Tzahala Tzuk-Shina
Dr. Tzahala Tzuk-Shina
Head of Neuro-oncology Clinic, Rambam Medical Center

Belong group – Brain & Nervous Sys. Cancer MD
Dr. Tzahala Tzuk-Shina is the Head of the Neuro-oncology Clinic at the Rambam Medical Center. She completed her MD degree at the Technion Haifa and became a senior specialist in neurology at Carmel, Lady Davis hospital. She did her fellowship in Neuro-Oncology at the Hadassah Medical Center. In 1994 she founded the Neuro-Oncology Clinic at the Rambam Medical Center and became the Head of the service. Her main occupations are treatment of patients with brain and central nervous system tumors, as well as cancer and treatment related neurological complications. She’s involved extensively in clinical trials on brain tumors acting as principal investigator.

Dr. Daniel Vorobiof,Chief Medical Director at Belong.Life
Dr. Daniel A. Vorobiof
Chief Medical Director, Belong

Belong group – Ask the Oncologist
Dr. Daniel A. Vorobiof founder of the Sandton Oncology Centre in Johannesburg, South Africa since 1989 until 2018. Dr. Daniel A. Vorobiof completed his MD degree from the University of Cordoba, Argentina, and a Doctor in Medicine degree from the University of Pretoria, South Africa. He have been working in Medical Oncology since 1980, a member of several national and international oncologic societies. Currently he is a member of the European School of Oncology (ESO) Core Faculty in Breast Cancer and Malignant Melanoma. He is also on the Editorial Board of various international oncologic medical journals and the editor of 2 magazines.He was a founder member and a chairman of several South African Medical Oncology Societies, He had been involved in clinical research nationally and internationally and published more than 100 research articles in medical oncology journals.

Dr. Luba Vasilenko
Dr. Luba Vasilenko
Head of the Intermediate Cardiac Care Unit

Belong group – Cardio-Oncology MD
Dr. Luba Vasilenko, Head of the Intermediate Cardiac Care Unit and the chairman of the Cardio-Oncologic Clinic at the Assuta Ashdod Medical Center. Dr. Luba Vasilenko completed his MD degree at the Altaisk Medical Royal University in Russia. He completed his internal medicine residence at the Sheba Medical Center and the cardiology residence at the Hillel Yaffe Medical Center.He has more than ten years of experience as a cardiologist and have been working in Cardio-Oncologic clinics since 2014. I published several papers and am involved in several clinical trials. Dr. Luba Vasilenko is active member of the European Cardiology Society.

Dr. Ofer Purim
Dr. Ofer Purim
Chief Gastrointestinal Malignancy Service

Belong group – Stomach & Esophageal Cancer MD
Dr. Ofer Purim is the Chief of the gastrointestinal malignancy service at the new Assuta University Hospital. He graduated with honors at the Szeged University in Hungary, completed his residency at the Davidoff Cancer Center at the Beilinson Hospital and worked as a senior physician at the Davidoff center in the gastrointestinal unit. Dr. Purim specializes in treatment of rare tumors of the GI tract such as GIST and neuroendocrine tumors and has over 14 years of experience in the field. Dr. Purim is very active in researches and served as a primary investigator and sub investigator in dozens of local and international trials. He has published 32 manuscripts in his field and is a lecturer to physicians, nurses and for the public. Dr. Purim is a member of the Executive Committee of the Israeli Society for Oncology and Radiotherapy.

Dr. Osher Esther
Dr. Esther Osher-Afingendin
Senior physician, Institute of Endocrinology

Belong group – Neuro Endocrine Tumors MD
Dr. Esther Osher, is the head of the neuroendocrine tumor unit at the Institute of Endocrinology , Tel Aviv Souraski Medical Center(TASMC). Graduated medical School, at the Technicon Haifa, and PhD degree at Sackler Faculty of Medicine, Tel -Aviv University. She is a specialist in Internal medicine and Endocrinology since 2002, since then she is a senior physician at the institute of endocrinology at TASMC. Dr. Osher is a member in several medical associations in Israel and worldwide, published medical papers and a lectures at the Sackler School of Medicine TAU.

Dr. Daniel Keizman
Dr. Daniel Keizman
Head of Genitourinary Oncology Unit

Belong group – Prostate & Testicular Can. MD
Dr. Daniel Keizman, is the Head of the Genitourinary Oncology Unit, at the Division of Oncology, at the Tel-Aviv Sourasky Medical Center, Israel. Dr Keizman graduated from the Sackler Faculty of Medicine, Tel Aviv University. He is board certified in internal medicine and medical Oncology (trained at the Tel-Aviv Sourasky Medical Center). He did his post doctoral clinical fellowship in genitourinary oncology during the years 2008-2001 at the Kimmel Cancer Center, Johns Hopkins Hospital, Baltimore, USA. Dr Keizman’s current research activity, focuses on genitourinary oncology. He is the author of numerous studies and review articles published in medical journals, and presented numerous studies in international meetings. He is a member of the American Society of Clinical Oncology and the Israel Society of Clinical Oncology

Dr. Yair Peled
Dr. Yair Peled
Senior Doctor, Pediatric Hemato-Oncology

Belong group – Children Oncology MD
Yair Peled. a senior doctor at the pediatric hemato-oncology and bone marrow transplant department at the Tel Aviv Sourasky medical center. Dr. Yair Peled treat pediatric patients that suffer from solid tumors and mainly sarcomas. He graduated from medical school at the Hebrew University, completed his residency in pediatrics at Sha’arei Tzedek medical center, and graduated pediatric hematology and oncology residency at the Hadassah medical center.

Dr. Tomer Charas
Dr. Tomer Charas
Head of Genitourinary Oncology unit

Belong group – Prostate & Testicular Can. MD, Kidney & Bladder Cancer MD
Dr. Tomer Charas, Heads of the Genitourinary oncology unit at the Oncology Division at the Rambam Health Care Campus, Haifa, Israel. He is a board-certified radiation oncologist, specializing in radiation therapy treatments of the genitourinary tract cancers. He graduated from Semmelweis University medical school, Budapest, Hungary with honors. After completing his radiation oncology residency training at Rambam Health Care Campus, He completed radiation oncology Genitourinary fellowship program and additionally Brachytherapy fellowship program, both at Memorial Sloan Kettering Cancer Center NYC, NY. He’s involved in prostate brachytherapy (implanting radioactive sources in the prostate – a minimally invasive procedure), SBRT (highly focused radiotherapy treatments), researching and implementing new technologies aiming to improve patients’ care and reduce side effects from treatments. Dr. Charas is a member of the EORTC, ABS and Amercian Society for Radiation Oncology (ASTRO).

Dr. Roy Mano
Dr. Roy Mano
Senior Urologist

Belong group – Kidney & Bladder Cancer MD
Dr. Roy Mano serves as an attending physician in the Urology Department at Tel-Aviv Sourasky Medical Center. He is a board certified urologist focused on the treatment of patients with urologic malignancies including bladder, kidney and prostate cancers. Dr. Mano received his medical degree from The Ruth & Bruce Rappaport Faculty of Medicine at the Technion – Israel Institute of Technology where he graduated with honors. After finishing the Urology residency training program at Rabin Medical Center, he completed a two year Society of Urologic Oncology fellowship at Memorial Sloan Cancer Center in New York. During his fellowship he trained in both open and robotic surgeries for the treatment of urologic malignancies. In addition to his clinical duties Dr. Mano is involved in clinical and translational research focused on bladder and kidney cancer, with the aim of improving our ability to personalize treatment options for patients diagnosed with cancers involving the genito-urinary tract

Dr. Ofer Margalit
Senior Medical Oncologist

Belong Group – Liver & Bile Duct Cancer MD
Dr. Margalit is a senior physician-scientist in the field of medical oncology at Sheba Medical Center, specializing in gastrointestinal malignancies, in particular hepatocellular carcinoma, and cholangiocarcinoma.

He graduated from Tel-Aviv University Medical School in Israel and completed his post-doctoral studies at MD Anderson Cancer Center, Houston, TX. He published over 45 peer-reviewed articles and is a member of the American Society of Clinical Oncology (ASCO) and the American Association of Cancer Research (AACR).

Justine Friedman
Justine Friedman
Clinical Dietician

Belong group – Diet, Nutrition & Cancer
Justine Friedman a clinical dietician licensed in South Africa and Israel. Justine Friedman has been in practise for over 20 years. She is passionate about guiding people towards living a life with improved energy, health and vitality through nutrition education, personalised meal plans and guiding them to shift how they think and feel about their lives and bodies. This holistic approach has proven beneficial as different people have individual needs based on their chronic illness and life situation. One of the keys on a path of healing from cancer is to nourish one’s body as optimally as possible to reduce side effects of the disease and treatment process and halt or reverse the concerns of loss of lean muscle, inflammation and loss of appetite and taste which leads to lower immunity, fatigue and loss of quality of life.

Lizzie Rubin
Lizzie Rubin
Sex Therapist

Belong group – Sexuality & Cancer
Lizzie Rubin, I am a registered nurse, AASECT-certified sex therapist and cancer survivor. She switched fields years ago to become a sex therapist when a terminal oncology patient of her asked if he could make love to his wife when he went home for the weekend. In her mind, she had three questions: Why no one ever taught me this in nursing school? Why didn’t the doctors talk to him about it? And finally, is this what cancer patients think about — sex?? In a split second, she answered, “of course you may”, he was smiling from ear to ear.

Are Our
AI Cancer Mentor
Mel M.

Dave is an amazing Mentor. He seems to attract a lot of questions. His answers are by the book… He has a sense of humor…

AI Oncology Mentor

Thanks Dave, first time an AI spoke to me, not to software advice. I am not sure if I’m ready to feel better, but your words were thoughtful and appreciated, thank you.

AI Cancer Mentor
Alice D.

Dave, the AI mentor, can tell you quickly and efficiently about the latest technological advances in oncology.

Belong Cancer Icon
Belong Cancer
Cookie F.

Belong is a great app. Helped me through my journey for sure. So many great people with great advice and suggestions. Awesome group.

AI Cancer Mentor
Grace G.

Yes, he is amazing I’m glad that he’s available to us.

Belong Cancer Icon
Belong Cancer
Cynthia S.

I have found great resources with this app. You can ask questions from professional and clinicians and get wonderful feedback. They will keep you informed about new clinical trials and everyone in the discussions
are sensitive and caring.

AI Cancer Mentor
Judith B.

He answered all my questions, and I didn’t have to wait for a human answer. His knowledge is superb.

Belong Cancer Icon
Belong Cancer
Herbyka Y.

So grateful to have an application such as Belong that connects and helps people to manage and live with Cancer.

AI Cancer Mentor
Brenda D.

The AI cancer mentor is a great accomplishment and a fantastic helping tool for so many patients and caregivers.

Belong Cancer Icon
Belong Cancer
Jennifer C.I.M

Cancer is really a scary thing. To have this kind of support and hope is vital to healing

AI Cancer Mentor
Linda L.

Thank you, Dave, for being here!!!!

Belong Cancer Icon
Belong Cancer
Victoria M.

It’s awesome to be able to have your questions answered by other people going through the same thing as you are and having the option to ask a doctor as well.

AI Cancer Mentor
Mark W.

I have asked Dave the AI Mentor some very complicated questions that I already know the answers to, and Dave has always been spot on.

Belong Cancer Icon
Belong Cancer
Kristin L.

Exceptional! Love it!

Among our Customers & Partners

Skip to content